It was also shown that low IL-6 expression is required for the strong anti-tumor effect of DSP-0509 in the combination with RT, but may be the result of the anti-tumor effect since IL-6 acts negatively on the activation of CTLs [31]. Here, IL6 is linked to neoplasm.